A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

Jade Howard1 Division of Neuroscience and Neuroscience Institute, The University of Sheffield, Sheffield, UKView further author information

Hilary L. Bekker2 Leeds Unit for Complex Intervention Development, The University of Leeds, Leeds, UKView further author information

Christopher J. Mcdermott1 Division of Neuroscience and Neuroscience Institute, The University of Sheffield, Sheffield, UK;3 Academic Directorate of Neuroscience, Royal Hallamshire Hospital, Sheffield, UK and

https://orcid.org/0000-0002-1269-9053 View further author information

Alisdair Mcneill1 Division of Neuroscience and Neuroscience Institute, The University of Sheffield, Sheffield, UK;4 Sheffield Clinical Genetics Service, Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UKCorrespondencea.mcneill@:sheffield.ac.uk
View further author information

References

Crook A, McEwen A. Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first. Eur J Hum Genet. 2022;30:394–5.
PubMed Web of Science ®Google Scholar
NICE. Shared decision making, NICE guideline. June 17, 2021. Available at: https://www.nice.org.uk/guidance/ng197. Accessed November 27, 2023.
Google Scholar
Salmon K, Ross JP, Bertone V, Gobbo M, Anoja N, Karamchandani J, et al. The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis. Eur J Hum Genet. 2022;30:1205–7.
PubMed Web of Science ®Google Scholar
Crook A, Jacobs C, Newton‐John T, McEwen A. Genetic counseling and diagnostic genetic testing for familial amyotrophic lateral sclerosis and/or frontotemporal dementia: a qualitative study of client experiences. J Genet Couns. 2022;31:1206–18.
PubMed Web of Science ®Google Scholar
Bekker HL, Winterbottom AE, Gavaruzzi T, Finderup J, Mooney A. Decision aids to assist patients and professionals in choosing the right treatment for kidney failure. Clin Kidney J. 2023;16:i20–i38.
PubMed Web of Science ®Google Scholar
De Oliveira HM, Soma A, Baker MR, Turner MR, Talbot K, Williams TL. A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:405–13.
PubMed Web of Science ®Google Scholar

A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date